Molecular characterization of renal cell carcinoma tumors from a phase iii anti-angiogenic adjuvant therapy trial

HIGHLIGHTS

  • who: Robert J. Motzer from the (UNIVERSITY) have published the article: Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial, in the Journal: (JOURNAL) of 22/09/2022
  • what: The authors report a comprehensive genomic and transcriptomic analysis of tumor samples from 171 patients at high risk for recurrent renal cell carcinoma post nephrectomy from the S-TRAC trial (NCT00375674). The authors focused on the sunitinib treatment arm of the S-TRAC study to identify molecular characteristic that might associate with the resistance to anti-angiogenesis adjuvant treatment . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?